Gregory Ackroyd, MD
Neurology · Anaheim
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 26 years
- New York University School of Medicine, 2000
Offices
4 locations · Providence Medical Foundation · 1,461 clinicians in this group
Hospitals listed: Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ackroyd’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A84348 · Current
Licensed to practise in California · since 2003 · expires 2027-07-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Neurology
- American Board of Psychiatry and Neurology - Sleep Medicine
- American Board of Sleep Medicine - Sleep Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$129,705
Medicare paid this office $129,705 for 694 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 352 | $47,345 | $101 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 258 | $27,909 | $101 |
| New patient visit (45+ min) | 191 | $25,235 | $132 |
| Sleep study in sleep lab (6 years or older) | 110 | $11,277 | $101 |
| New patient visit (60+ min) | 74 | $9,951 | $134 |
See all 7 services
| Return visit (30+ min) | 352 | $47,345 | $101 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 258 | $27,909 | $101 |
| New patient visit (45+ min) | 191 | $25,235 | $132 |
| Sleep study in sleep lab (6 years or older) | 110 | $11,277 | $101 |
| New patient visit (60+ min) | 74 | $9,951 | $134 |
| Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 79 | $6,185 | $78 |
| Short return visit (20+ min) | 11 | $945 | $79 |
Who their Medicare patients are
694 Original Medicare patients in 2024. Average age 72 · Under 65 9% · 85 and older 6% · Women 48% · Also on Medicaid 16% · Health risk score 1.04. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 66% · Coronary heart disease 27% · Diabetes 25% · Depression 24% · Atrial fibrillation 22% · Chronic kidney disease 15% · Heart failure 12% · Cancer 12% · COPD 9% · Stroke 7% · Dementia 4%.
The office billed $554,309, Medicare allowed $175,636 and paid $129,705; for 1,228 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 694 | 1,228 | 72 | 1.04 | $554,309 | $129,705 |
| 2023 | 620 | 1,024 | 72 | 1.03 | $851,284 | $109,640 |
| 2022 | 594 | 954 | 72 | 1.08 | $891,879 | $101,624 |
| 2021 | 509 | 854 | 71 | 1.00 | $344,505 | $90,592 |
| 2020 | 812 | 1,276 | 72 | 1.10 | $463,317 | $120,916 |
| 2019 | 854 | 1,478 | 72 | 1.10 | $611,492 | $153,388 |
| 2018 | 974 | 1,613 | 72 | 1.17 | $609,608 | $151,764 |
| 2017 | 1,111 | 2,056 | 71 | 1.21 | $654,345 | $190,621 |
| 2016 | 951 | 1,841 | 71 | 1.18 | $591,622 | $169,948 |
| 2015 | 861 | 1,872 | 70 | 1.11 | $584,219 | $172,695 |
| 2014 | 726 | 1,499 | 69 | 1.13 | $501,368 | $164,223 |
| 2013 | 455 | 921 | 72 | 1.02 | $310,535 | $172,128 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Return visit (30+ min) | 366 | $47,941 | $100 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 197 | $22,633 | $107 |
| New patient visit (45+ min) | 174 | $20,825 | $120 |
| Sleep study in sleep lab (6 years or older) | 87 | $9,404 | $106 |
| New patient visit (60+ min) | 35 | $6,564 | $188 |
| Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | 14 | $1,106 | $79 |
2022: 5 services
| Return visit (30+ min) | 290 | $39,978 | $101 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 261 | $27,770 | $101 |
| New patient visit (45+ min) | 144 | $18,678 | $130 |
| Sleep study in sleep lab (6 years or older) | 76 | $8,474 | $110 |
| New patient visit (60+ min) | 37 | $5,473 | $148 |
2021: 8 services
| Return visit (30+ min) | 238 | $34,011 | $107 |
| New patient visit (60+ min) | 101 | $16,607 | $164 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 133 | $12,957 | $95 |
| Sleep study in sleep lab (6 years or older) | 104 | $11,236 | $107 |
| New patient visit (45+ min) | 61 | $8,367 | $137 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 39 | $2,442 | $63 |
| Sleep study including heart rate, breathing, airflow, and effort | 44 | $1,638 | $37 |
| Short return visit (20+ min) | 14 | $1,088 | $68 |
2020: 10 services
| Return visit (30+ min) | 407 | $40,506 | $85 |
| New patient visit (60+ min) | 157 | $23,647 | $151 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 197 | $20,915 | $102 |
| New patient visit (45+ min) | 86 | $11,707 | $136 |
| Sleep study in sleep lab (6 years or older) | 97 | $9,027 | $93 |
| Short return visit (20+ min) | 69 | $4,627 | $62 |
| Sleep study including heart rate, breathing, airflow, and effort | 98 | $3,462 | $35 |
| New patient visit (30+ min) | 32 | $2,871 | $90 |
| Telephone medical discussion with physician, 21-30 minutes | 23 | $2,027 | $81 |
| Long return visit (40+ min) | 13 | $1,660 | $128 |
2019: 8 services
| New patient visit (60+ min) | 310 | $49,594 | $160 |
| Return visit (30+ min) | 455 | $48,403 | $84 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 322 | $35,201 | $100 |
| Sleep study in sleep lab (6 years or older) | 107 | $11,126 | $104 |
| Sleep study including heart rate, breathing, airflow, and effort | 70 | $2,781 | $39 |
| Long return visit (40+ min) | 21 | $2,541 | $121 |
| New patient visit (45+ min) | 18 | $2,229 | $124 |
| New patient visit (30+ min) | 11 | $668 | $61 |
2018: 7 services
| Return visit (30+ min) | 649 | $60,680 | $75 |
| New patient visit (60+ min) | 238 | $36,143 | $152 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 302 | $35,298 | $101 |
| Sleep study in sleep lab (6 years or older) | 118 | $12,154 | $102 |
| Long return visit (40+ min) | 23 | $2,458 | $107 |
| Sleep study including heart rate, breathing, airflow, and effort | 40 | $2,023 | $48 |
| New patient visit (45+ min) | 15 | $1,909 | $127 |
2017: 8 services
| Return visit (30+ min) | 871 | $99,779 | $80 |
| New patient visit (60+ min) | 249 | $37,712 | $151 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 309 | $34,330 | $99 |
| Sleep study in sleep lab (6 years or older) | 97 | $9,639 | $99 |
| New patient visit (45+ min) | 24 | $2,885 | $120 |
| Long return visit (40+ min) | 21 | $2,484 | $118 |
| Sleep study including heart rate, breathing, airflow, and effort | 28 | $1,361 | $49 |
| Short return visit (20+ min) | 24 | $1,316 | $49 |
2016: 7 services
| Return visit (30+ min) | 733 | $87,972 | $80 |
| New patient visit (60+ min) | 221 | $33,278 | $151 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 290 | $32,482 | $98 |
| Sleep study in sleep lab (6 years or older) | 86 | $8,569 | $98 |
| New patient visit (45+ min) | 19 | $2,558 | $135 |
| New patient visit (30+ min) | 19 | $1,621 | $85 |
| Short return visit (20+ min) | 17 | $1,199 | $60 |
2015: 7 services
| Return visit (30+ min) | 610 | $77,464 | $82 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 306 | $35,195 | $100 |
| New patient visit (60+ min) | 221 | $34,494 | $156 |
| Short return visit (20+ min) | 155 | $10,582 | $53 |
| Sleep study in sleep lab (6 years or older) | 59 | $5,804 | $98 |
| New patient visit (45+ min) | 43 | $5,447 | $127 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 13 | $1,315 | $101 |
2014: 6 services
| Return visit (30+ min) | 525 | $63,003 | $80 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 250 | $48,019 | $173 |
| New patient visit (60+ min) | 182 | $27,980 | $154 |
| Sleep study in sleep lab (6 years or older) | 59 | $11,522 | $195 |
| Short return visit (20+ min) | 110 | $6,822 | $58 |
| New patient visit (45+ min) | 50 | $5,646 | $113 |
2013: 6 services
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 123 | $82,478 | $569 |
| Return visit (30+ min) | 350 | $46,975 | $86 |
| Sleep study in sleep lab (6 years or older) | 33 | $18,435 | $542 |
| New patient visit (60+ min) | 99 | $16,080 | $162 |
| New patient visit (45+ min) | 32 | $4,001 | $125 |
| Short return visit (20+ min) | 47 | $2,590 | $54 |
Medicaid work
$105,478 in 2024
Medicaid paid $105,478 for 916 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 136 | $31,221 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 85 | $21,950 |
| Return visit (30+ min) | 395 | $21,864 |
| New patient visit (45+ min) | 173 | $18,152 |
| New patient visit (60+ min) | 83 | $10,584 |
| Short return visit (20+ min) | 30 | $1,152 |
| Sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time | 14 | $556 |
| 2024 | 916 | 7 | 49 | $105,478 |
| 2023 | 761 | 6 | 51 | $72,708 |
| 2022 | 841 | 7 | 46 | $85,605 |
| 2021 | 749 | 6 | 53 | $75,165 |
| 2020 | 557 | 6 | 52 | $54,313 |
| 2019 | 596 | 5 | 44 | $70,747 |
| 2018 | 597 | 4 | 38 | $77,788 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 475 | $25,699 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 90 | $18,379 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 45 | $12,418 |
| New patient visit (60+ min) | 73 | $8,950 |
| New patient visit (45+ min) | 66 | $6,826 |
| Sleep study, unattended, simultaneous recording; heart rate, oxygen saturation, respiratory analysis (eg, by airflow or peripheral arterial tone), and sleep time | 12 | $436 |
2022
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 142 | $31,356 |
| Return visit (30+ min) | 429 | $23,536 |
| New patient visit (45+ min) | 134 | $13,749 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 65 | $8,387 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 26 | $5,616 |
| New patient visit (60+ min) | 17 | $1,885 |
| Short return visit (20+ min) | 28 | $1,075 |
2021
| Return visit (30+ min) | 470 | $27,836 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 68 | $17,650 |
| New patient visit (45+ min) | 125 | $13,383 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 49 | $11,380 |
| New patient visit (60+ min) | 24 | $3,229 |
| Sleep study, unattended, simultaneous recording of, heart rate, oxygen saturation, respiratory airflow, and respiratory effort (eg, thoracoabdominal movement) | 13 | $1,686 |
2020
| Return visit (30+ min) | 375 | $22,684 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 63 | $16,272 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 26 | $6,287 |
| New patient visit (45+ min) | 40 | $4,410 |
| New patient visit (60+ min) | 29 | $3,731 |
| Short return visit (20+ min) | 24 | $929 |
2019
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 120 | $29,881 |
| Return visit (30+ min) | 339 | $20,388 |
| New patient visit (60+ min) | 100 | $13,120 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 25 | $6,021 |
| New patient visit (45+ min) | 12 | $1,337 |
2018
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, with initiation of continuous positive airway pressure therapy or bilevel ventilation, attended by a technologist | 127 | $33,749 |
| New patient visit (60+ min) | 151 | $20,006 |
| Return visit (30+ min) | 293 | $17,517 |
| Polysomnography; age 6 years or older, sleep staging with 4 or more additional parameters of sleep, attended by a technologist | 26 | $6,516 |
Drugs they prescribed that Part D paid
$202,963
Pharmacies billed $202,963 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (12 of 296) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%. Long-acting opioids: 100% of their opioid prescriptions.
258 generic and 38 brand-name prescriptions · $202,963 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Armodafinil | 33 | $2,078 | $63 |
| Gabapentin | 62 | $795 | $13 |
| Fluticasone Propionate | 11 | $294 | $27 |
| Zolpidem | 21 | $243 | $12 |
| Methadone | 12 | $147 | $12 |
See all 8 drugs
| Armodafinil | 33 | $2,078 | $63 |
| Gabapentin | 62 | $795 | $13 |
| Fluticasone Propionate | 11 | $294 | $27 |
| Zolpidem | 21 | $243 | $12 |
| Methadone | 12 | $147 | $12 |
| Trazodone | 16 | $143 | $9 |
| Amitriptyline | 13 | $94 | $7 |
| Eszopiclone | 22 | $80 | $4 |
Year by year
| 2024 | 296 | 62 | 4% (12) | 13% | $202,963 |
| 2023 | 241 | 64 | 5% (12) | 15% | $35,658 |
| 2022 | 235 | 55 | 5% (12) | None | $21,219 |
| 2021 | 209 | 45 | 14% (29) | 18% | $37,515 |
| 2020 | 275 | 44 | 11% (29) | 13% | $166,924 |
| 2019 | 292 | 58 | 11% (32) | 12% | $204,824 |
| 2018 | 416 | 76 | 7% (30) | 15% | $147,170 |
| 2017 | 477 | 98 | 7% (31) | 17% | $44,587 |
| 2016 | 509 | 102 | 6% (31) | 28% | $151,602 |
| 2015 | 551 | 108 | 4% (21) | 25% | $137,602 |
| 2014 | 580 | 100 | 2% (14) | 20% | $69,358 |
| 2013 | 510 | 83 | None | 26% | $68,602 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Armodafinil | 31 | $1,959 | $63 |
| Gabapentin | 22 | $470 | $21 |
| Fluticasone Propionate | 20 | $413 | $21 |
| Trazodone | 19 | $316 | $17 |
| Methadone | 12 | $150 | $12 |
| Eszopiclone | 14 | $90 | $6 |
| Zolpidem | 20 | $49 | $2 |
2022: 9 drugs
| Armodafinil | 22 | $1,688 | $77 |
| Zolpidem Tartrate Er | 11 | $1,519 | $138 |
| Modafinil | 14 | $906 | $65 |
| Fluticasone Propionate | 18 | $271 | $15 |
| Zolpidem | 32 | $270 | $8 |
| Trazodone | 28 | $222 | $8 |
| Gabapentin | 15 | $213 | $14 |
| Temazepam | 14 | $136 | $10 |
| Eszopiclone | 12 | $70 | $6 |
2021: 7 drugs
| Xtampza Er | 14 | $22,106 | $1,579 |
| Zolpidem | 31 | $1,625 | $52 |
| Modafinil | 20 | $1,189 | $59 |
| Trazodone | 16 | $319 | $20 |
| Fluticasone Propionate | 18 | $240 | $13 |
| Eszopiclone | 13 | $106 | $8 |
| Temazepam | 14 | $57 | $4 |
2020: 12 drugs
| Oxycontin | 12 | $12,511 | $1,043 |
| Armodafinil | 17 | $2,178 | $128 |
| Ropinirole Er | 12 | $1,140 | $95 |
| Zolpidem | 46 | $1,067 | $23 |
| Modafinil | 12 | $1,003 | $84 |
| Trazodone | 25 | $634 | $25 |
| Ropinirole | 13 | $407 | $31 |
| Eszopiclone | 23 | $359 | $16 |
| Clonazepam | 22 | $226 | $10 |
| Fluticasone Propionate | 13 | $164 | $13 |
| Temazepam | 14 | $44 | $3 |
| Methadone | 12 | $40 | $3 |
2019: 12 drugs
| Xyrem | 12 | $176,291 | $14,691 |
| Oxycontin | 12 | $12,057 | $1,005 |
| Zolpidem | 47 | $2,944 | $63 |
| Armodafinil | 18 | $2,360 | $131 |
| Modafinil | 15 | $2,061 | $137 |
| Ropinirole Er | 12 | $1,505 | $125 |
| Methylphenidate | 11 | $674 | $61 |
| Ropinirole | 24 | $656 | $27 |
| Gabapentin | 12 | $432 | $36 |
| Eszopiclone | 17 | $389 | $23 |
| Clonazepam | 36 | $198 | $6 |
| Methadone | 11 | $40 | $4 |
2018: 13 drugs
| Oxycontin | 12 | $11,037 | $920 |
| Zolpidem | 63 | $2,939 | $47 |
| Modafinil | 12 | $2,853 | $238 |
| Armodafinil | 21 | $1,884 | $90 |
| Eszopiclone | 36 | $1,530 | $43 |
| Methylphenidate | 12 | $981 | $82 |
| Ropinirole Er | 11 | $935 | $85 |
| Ropinirole | 20 | $506 | $25 |
| Gabapentin | 24 | $450 | $19 |
| Fluticasone Propionate | 25 | $284 | $11 |
| Clonazepam | 58 | $254 | $4 |
| Pramipexole Dihydrochloride | 17 | $213 | $13 |
| Methadone | 12 | $38 | $3 |
2017: 14 drugs
| Oxycontin | 12 | $8,325 | $694 |
| Nuvigil | 11 | $7,406 | $673 |
| Armodafinil | 32 | $5,724 | $179 |
| Zolpidem | 61 | $2,169 | $36 |
| Eszopiclone | 49 | $2,052 | $42 |
| Methylphenidate | 12 | $1,043 | $87 |
| Pramipexole Dihydrochloride | 25 | $737 | $29 |
| Ropinirole Er | 12 | $735 | $61 |
| Gabapentin | 30 | $444 | $15 |
| Clonazepam | 62 | $358 | $6 |
| Trazodone | 15 | $223 | $15 |
| Fluticasone Propionate | 20 | $203 | $10 |
| Montelukast | 14 | $116 | $8 |
| Methadone | 11 | $43 | $4 |
2016: 17 drugs
| Nuvigil | 31 | $23,151 | $747 |
| Clomipramine | 11 | $11,088 | $1,008 |
| Oxycontin | 12 | $6,438 | $536 |
| Breo Ellipta | 17 | $5,106 | $300 |
| Ropinirole Er | 14 | $1,446 | $103 |
| Eszopiclone | 30 | $982 | $33 |
| Methylphenidate | 13 | $972 | $75 |
| Proair Hfa | 12 | $920 | $77 |
| Ropinirole | 24 | $507 | $21 |
| Clonazepam | 62 | $429 | $7 |
| Gabapentin | 19 | $398 | $21 |
| Zolpidem | 46 | $354 | $8 |
| Pramipexole Dihydrochloride | 29 | $338 | $12 |
| Trazodone | 19 | $337 | $18 |
| Fluticasone Propionate | 15 | $138 | $9 |
| Alprazolam | 13 | $124 | $10 |
| Methadone | 11 | $47 | $4 |
2015: 18 drugs
| Nuvigil | 38 | $24,218 | $637 |
| Oxycontin | 11 | $5,197 | $472 |
| Ambien | 11 | $5,064 | $460 |
| Ropinirole Er | 17 | $4,909 | $289 |
| Eszopiclone | 24 | $1,237 | $52 |
| Methylphenidate | 12 | $1,009 | $84 |
| Zolpidem | 57 | $906 | $16 |
| Dextroamphetamine-Amphetamine | 12 | $648 | $54 |
| Temazepam | 14 | $615 | $44 |
| Pramipexole Dihydrochloride | 29 | $612 | $21 |
| Clonazepam | 67 | $445 | $7 |
| Gabapentin | 20 | $361 | $18 |
| Ropinirole | 24 | $317 | $13 |
| Fluticasone Propionate | 29 | $245 | $8 |
| Diazepam | 14 | $120 | $9 |
| Sertraline | 11 | $72 | $7 |
| Prednisone | 11 | $61 | $6 |
| Alprazolam | 11 | $47 | $4 |
2014: 14 drugs
| Nuvigil | 59 | $33,931 | $575 |
| Ropinirole | 58 | $5,106 | $88 |
| Pramipexole Dihydrochloride | 50 | $1,509 | $30 |
| Amphetamine Salt Combo | 15 | $912 | $61 |
| Gabapentin | 14 | $576 | $41 |
| Zolpidem | 83 | $488 | $6 |
| Clonazepam | 63 | $452 | $7 |
| Eszopiclone | 12 | $425 | $35 |
| Fluticasone Propionate | 20 | $280 | $14 |
| Temazepam | 27 | $255 | $9 |
| Zaleplon | 12 | $180 | $15 |
| Diazepam | 19 | $132 | $7 |
| Alprazolam | 14 | $81 | $6 |
| Sertraline | 11 | $74 | $7 |
2013: 12 drugs
| Nuvigil | 75 | $35,925 | $479 |
| Modafinil | 15 | $10,928 | $729 |
| Ropinirole | 71 | $4,596 | $65 |
| Venlafaxine Hcl Er | 13 | $1,892 | $146 |
| Nasonex | 11 | $1,556 | $141 |
| Pramipexole Dihydrochloride | 30 | $1,414 | $47 |
| Amphetamine Salt Combo | 15 | $821 | $55 |
| Clonazepam | 60 | $561 | $9 |
| Zolpidem | 69 | $419 | $6 |
| Temazepam | 30 | $254 | $8 |
| Alprazolam | 13 | $96 | $7 |
| Diazepam | 12 | $86 | $7 |
Money from drug and device companies
$435 in 2025
| 2025 | 9 | 16 | None | $435 |
| 2024 | 11 | 17 | None | $583 |
| 2023 | 7 | 15 | None | $501 |
| 2022 | 5 | 11 | None | $482 |
| 2021 | 6 | 22 | $28 | $491 |
| 2020 | 4 | 21 | None | $311 |
| 2019 | 3 | 9 | None | $389 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Avadel CNS Pharmaceuticals | Lumryz | $122 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $95 | 3 payments
|
| Philips North America | Nasal Masks - Over the Head | $57 | 2 payments
|
| Baxter Healthcare | Hillrom - Monarch Airway Clearance System | $43 | 2 payments
|
| Inspire Medical Systems | Inspire | $32 | 1 payment
|
| Harmony Biosciences | Wakix | $28 | 1 payment
|
See all 16 published payments
| Baxter Healthcare | Meals · 2025-12-09 | Hillrom - Monarch Airway Clearance System | $24 |
| Avadel CNS Pharmaceuticals | Meals · 2025-11-18 | Lumryz | $27 |
| ZOLL Respicardia | Meals · 2025-11-04 | Remede System | $17 |
| Philips North America | Meals · 2025-10-22 | Vest Therapy Und | $22 |
| Inspire Medical Systems | Meals · 2025-08-14 | Inspire | $32 |
| Avadel CNS Pharmaceuticals | Meals · 2025-08-06 | Lumryz | $25 |
| Axsome Therapeutics | Meals · 2025-07-19 | Sunosi | $20 |
| Philips North America | Meals · 2025-07-14 | Nasal Masks - Over the Head | $35 |
| Avadel CNS Pharmaceuticals | Meals · 2025-06-20 | Lumryz | $35 |
| Baxter Healthcare | Meals · 2025-06-11 | Hillrom - Monarch Airway Clearance System | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-05-13 | Dupixent | $34 |
| Lilly USA | Meals · 2025-03-21 | Zepbound | $19 |
| Harmony Biosciences | Meals · 2025-03-11 | Wakix | $28 |
| Regeneron Healthcare Solutions | Meals · 2025-02-26 | Dupixent | $35 |
| Avadel CNS Pharmaceuticals | Meals · 2025-02-07 | Lumryz | $34 |
| Regeneron Healthcare Solutions | Meals · 2025-01-15 | Dupixent | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $583
| Philips North America | (Di2) Nasal Masks - Over the Head | $194 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $92 | 3 payments
|
| Harmony Biosciences | Wakix | $85 | 1 payment
|
| Itamar Medical | Watchpatone | $55 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 1 payment
|
| Genzyme | Dupixent | $35 | 1 payment
|
| Avadel CNS Pharmaceuticals | Lumryz | $28 | 1 payment
|
| GlaxoSmithKline | Nucala | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $17 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $16 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $4 | 1 payment
|
2023: $501
| Jazz Pharmaceuticals | Xywav | $182 | 4 payments
|
| Philips Electronics North America | (6299) Dreamwear | $130 | 5 payments
|
| Itamar Medical | Watchpatone | $95 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Glassia | $31 | 1 payment
|
| Genzyme | Dupixent | $28 | 1 payment
|
| Baxter Healthcare | Hillrom - Vest System Model 105 Home Care | $18 | 1 payment
|
| Axsome Therapeutics | Sunosi | $17 | 1 payment
|
2022: $482
| Jazz Pharmaceuticals | Xyrem | $164 | 4 payments
|
| Philips Electronics North America | (8300) Dreamstat Bipap Auto | $135 | 3 payments
|
| Itamar Medical | Watchpat | $117 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $35 | 2 payments
|
| Harmony Biosciences | Wakix | $30 | 1 payment
|
2021: $491
| Philips Electronics North America | (8357) Dreamwear Full | $199 | 6 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $121 | 8 payments
|
| Jazz Pharmaceuticals | Xywav | $81 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $33 | 1 payment
|
| Resmed | Airsense | $29 | 2 payments
|
| Itamar Medical | Watchpat | $28 | 1 payment
|
2020: $311
| GlaxoSmithKline | Trelegy Ellipta | $199 | 14 payments
|
| Jazz Pharmaceuticals | Sunosi | $58 | 3 payments
|
| Philips Electronics North America | (6299) Dreamwear | $36 | 3 payments
|
| Resmed | Airfit | $18 | 1 payment
|
2019: $389
| Philips Electronics North America | Dreamwisp | $298 | 5 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $49 | 2 payments
|
| Jazz Pharmaceuticals | Sunosi | $42 | 2 payments
|
Professional record
- NPI
- 1538192984
- Licence
- CA A84348California A84348: Current · expires 2027-07-31
- Trained
- New York University School of Medicine, 2000 · 26 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- NC 5901340
- Taxonomy
- Federal specialty code 2084S0012X (2084S0012X); Neurology (2084N0400X)
- Mailing address
- 585 W College Ave, Santa Rosa, CA, 95401
- NPI first listed
- 2006-07-09
- NPI last updated
- 2021-10-14
- NPI record certified
- 2021-10-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.